Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel photosensitizing agents prepared at Mallinckrodt

June 16, 2011

Veliparib/temozolomide combination is safe in metastatic unresectable CRC

June 16, 2011

Phase I/II data on navitoclax in lymphoid malignancies updated

June 16, 2011

MEGF-0444A is safe as monotherapy or combined with bevacizumab/paclitaxel in solid tumors

June 16, 2011

CytRx reports encouraging preliminary data from phase II ENABLE trial of bafetinib in B-CLL

June 15, 2011

Bayer HealthCare submits IND application for BAY-94-9343

June 15, 2011

MLN-4924 has effects in acute myeloid leukemia and high-grade myelodysplastic syndrome

June 15, 2011

Novel anticancer macrocyclic lactones presented

June 15, 2011

KIST researchers prepare new protein kinase inhibitors

June 15, 2011

First-in-human data suggest safety of LY-2090314 in patients with advanced solid tumors

June 15, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...